Skip to main content
. 2022 Sep 24;27:109–130. doi: 10.1016/j.omtm.2022.09.010

Figure 6.

Figure 6

Gene therapy with LV-IGF2.GAAco relieves astrogliosis in brain

(A–D) Sagittal sections of hippocampus, corpus callosum, and thalamus after high-dose gene therapy stained for GFAP (red) and LAMP1 (green). An overview of the stained area is presented in (A). Scale bar, 500 μm. Boxed areas in (A) are magnified in (B) (1, hippocampus), (C) (2, corpus callosum), and (D) (3, thalamus). Scale bar, 25 μm.